earnings
confidence high
sentiment positive
materiality 0.75
LeMaitre Q2 sales $70.4M (+10%), EPS $0.74 (+23%); Artegraft up 34%; guides FY $276.3M
LEMAITRE VASCULAR INC
- Sales $70.4M, +10% YoY (+10% organic); EPS $0.74 (+23%).
- Gross margin 72.1% (+210 bps); operating income $20.4M (+26%).
- Artegraft sales +34%; approved in 56 countries, 21% of sales.
- FY guidance: sales mid $276.3M (+11% org), EPS mid $2.89 (+15% GAAP, +21% adj).
- Quarterly dividend $0.25/share payable Sept 3, 2026 to record Aug 20, 2026.